Psychedelics Market Soars: Wells Fargo Projects $11 Billion by 2035
Wells Fargo’s latest analysis projects significant growth for branded psychedelic treatments, estimating the market for depression-related applications could reach an impressive $11 billion by 2035. This forecast underscores a burgeoning sector within pharmaceuticals, driven by innovative approaches to mental health care. The bank’s research encompassed several key players in the space, including CMPS, DFTX, GHRS, … Read more









